PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.\', \'Department of Biology, University of Ottawa, Ottawa, ON K1N 6N5, Canada.\', \'Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.\', \'Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.\', \'Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON M5G 1X5, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.\', \'Department of Pathology and Molecular Medicine, Queens University, Kingston, ON K7L 3N6, Canada.\', \'Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada. Electronic address: jbell@ohri.ca.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1525-0016(21)00074-510.1016/j.ymthe.2021.02.007
?:doi
?:hasPublicationType
?:journal
  • Molecular therapy : the journal of the American Society of Gene Therapy
is ?:pmid of
?:pmid
?:pmid
  • 33578036
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all